In fact, in DSS-AOM-treated mice, transient ablation of CD4/Foxp3 Treg, during the carcinogenesis, suppressed tumor outgrowth and distribution, accompanied by an increased number of CD8 effector T cells8. This evidence concerns the gene CD8A and neoplasm.